Tyra Biosciences, Inc.
Clinical-stage biotech developing precision medicines targeting FGFR biology.
TYRA | US
Overview
Corporate Details
- ISIN(s):
- US90240B1061
- LEI:
- Country:
- United States of America
- Address:
- 2656 STATE STREET, 92008 CARLSBAD
- Website:
- https://tyra.bio/
Description
Tyra Biosciences, Inc. is a clinical-stage biotechnology company focused on developing next-generation precision medicines. The company specializes in therapies targeting fibroblast growth factor receptor (FGFR) biology, aiming to overcome tumor resistance and address key drivers of disease. Utilizing its proprietary SNÅP Discovery Engine, Tyra Biosciences designs innovative molecular structures. Its lead clinical program involves the development of oral dabogratinib for the treatment of skeletal dysplasia and urologic cancers.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Tyra Biosciences, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Tyra Biosciences, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Tyra Biosciences, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
